Sopan Pharmaceuticals IPO Allotment Completed; Over 347,000 Applicants Receive Shares
The IPO allotment of Sopan Pharmaceuticals Limited has been finalized, with more than 347,000 applicants receiving 10 units each while many others remained unallotted.
Sopan Pharmaceuticals Limited has successfully completed the allotment of its Initial Public Offering (IPO) issued to the general public. The allotment process was carried out this morning by the issue manager, NMB Capital.
The company had issued a total of 3,474,900 shares to the public from April 15 to April 20 (Baisakh 3–8). The IPO witnessed strong demand from investors across the country.
According to the allotment results, a total of 347,490 applicants received shares at a minimum of 10 units each, while the remaining applicants were left without allocation due to oversubscription.
Applicants can check their IPO results through the official website of CDSC by selecting the company name and entering their 16-digit BOID number.